Blue Apron vs Johnson & Johnson

Side-by-side comparison of AI visibility scores, market position, and capabilities

Johnson & Johnson leads in AI visibility (82 vs 60)
Blue Apron logo

Blue Apron

ChallengerSubscription Services

Meal Kit

Pioneering meal kit service acquired by Wonder Group in 2023; repositioned within Marc Lore's food delivery ecosystem alongside restaurant-quality delivery offerings.

AI VisibilityBeta
Overall Score
B60
Category Rank
#144 of 347
AI Consensus
94%
Trend
up
Per Platform
ChatGPT
57
Perplexity
59
Gemini
59

About

Blue Apron is a pioneering meal kit delivery service that delivers pre-portioned, fresh ingredients with step-by-step recipe cards to subscribers' homes, targeting home cooks who want to cook restaurant-quality meals without meal planning or grocery shopping. Founded in 2012 in New York City by Matt Salzberg, Ilia Papas, and Matthew Wadiak, Blue Apron went public in 2017 but struggled as competition intensified — HelloFresh, Home Chef, and Everyplate have all gained significant share. Blue Apron was acquired by Wonder Group in 2023 for approximately $103 million.

Full profile
Johnson & Johnson logo

Johnson & Johnson

LeaderConsumer Goods

Health & Wellness

FY2024 Sales: $88.8B (+4.3%) | Net Profit: $14.1B (+5.6%) | EPS: $5.79 | Adjusted EPS: $9.98 | FY2025 Guidance: Operational Sales Growth 2.5-3.5%, Adj EPS $10.75-$10.95 (+8.7% midpoint)

AI VisibilityBeta
Overall Score
A82
Category Rank
#19 of 347
AI Consensus
74%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
77
Gemini
82

About

Johnson & Johnson is one of the world's largest healthcare companies, founded in 1886 by brothers Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson in New Brunswick, New Jersey, where the company remains headquartered. Established to manufacture ready-to-use surgical dressings at a time when post-operative infection was a leading cause of surgical mortality, J&J was built on the scientific principles of antiseptic surgery advocated by Joseph Lister. The company trades on the NYSE under ticker JNJ and has evolved over 135+ years from a consumer health products manufacturer into a focused MedTech and pharmaceutical enterprise, completing the spinoff of its consumer health segment (Kenvue) in 2023.\n\nJohnson & Johnson now operates through two segments: Innovative Medicine and MedTech. Innovative Medicine encompasses oncology, immunology, neuroscience, infectious disease, and cardiovascular pharmaceutical products — including blockbusters Darzalex, Stelara, Tremfya, and Rybrevant. The MedTech segment includes surgical robotics (Ottava platform in development), electrophysiology (Abiomed, Biosense Webster), orthopedics (DePuy Synthes), and surgery systems, serving hospitals and surgical centers worldwide. Following the Kenvue separation, J&J is a pure-play healthcare technology and pharmaceutical company with significantly higher growth and margin profiles than its historical blended consumer-pharma-medtech structure.\n\nJohnson & Johnson reported FY2024 sales of $88.8 billion, up 4.3% year over year, with net profit of $14.1 billion, up 5.6%. The company's Innovative Medicine segment continues to grow driven by oncology and immunology portfolio strength, while MedTech benefits from procedure volume recovery and robotic surgery adoption. J&J's scale, R&D pipeline depth, and global commercial infrastructure — spanning more than 60 countries — position it as one of the two or three most consequential healthcare enterprises globally, with a patent portfolio, clinical trial network, and regulatory expertise that are nearly impossible to replicate.

Full profile

AI Visibility Head-to-Head

60
Overall Score
82
#144
Category Rank
#19
94
AI Consensus
74
up
Trend
stable
57
ChatGPT
83
59
Perplexity
77
59
Gemini
82
57
Claude
86
58
Grok
88

Key Details

Category
Meal Kit
Health & Wellness
Tier
Challenger
Leader
Entity Type
company
company

Capabilities & Ecosystem

Capabilities

Only Blue Apron
Meal Kit
Only Johnson & Johnson
Health & Wellness
Blue Apron is classified as company. Johnson & Johnson is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.